Nan Fung Life Sciences
Venture capital · San Francisco, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
2Deep-tech portfolio0 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Relay Therapeutics
32Co-investorsShare a portfolio company
Portfolio · 2 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Black Diamond Therapeutics | Biotech | Public | Dec 6, 2019 | $139.6M |
Peer ranks
Portfolio size#189
Portfolio exits#103
Raises, 12 months#88
Co-investors#55
Co-investors
- Boxer CapitalVenture capital2 shared
- Third Rock VenturesVenture capital2 shared
- Alexandria Venture InvestmentsVenture capital1 shared
- Apple Tree PartnersVenture capital1 shared
- Ascent Biomedical VenturesVenture capital1 shared
- Astellas Venture ManagementVenture capital1 shared
- Avoro Capital AdvisorsVenture capital1 shared
- Bay City CapitalVenture capital1 shared
- Biotechnology Value FundVenture capital1 shared
- Brookside CapitalVenture capital1 shared
Sectors
- Biotech2
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.